Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
What would be the outcome if your patient did not have alpha cells of the pancreas?
A. They would not be able to secrete insulin.
Alpha cells of the pancreas do not produce insulin. Insulin is produced by the beta cells of the pancreas. Therefore, the absence of alpha cells would not affect insulin secretion.
B. They would not be able to secrete glucagon.
The primary function of alpha cells in the pancreas is to produce and secrete glucagon. Glucagon is a hormone that raises blood glucose levels by promoting the conversion of glycogen to glucose in the liver. Without alpha cells, the body would not be able to secrete glucagon, leading to issues with glucose regulation.
C. They would not be able to secrete somatostatin and gastrin.
Somatostatin and gastrin are not secreted by alpha cells. Somatostatin is produced by delta cells of the pancreas and other parts of the digestive system, while gastrin is primarily produced by G cells in the stomach lining. Therefore, the absence of alpha cells would not affect the secretion of somatostatin and gastrin.
D. They would not be able to secrete pancreatic polypeptides.
Pancreatic polypeptides are produced by PP cells (pancreatic polypeptide cells) in the pancreas. The absence of alpha cells would not impact the secretion of pancreatic polypeptides.
This question is an excerpt from Nurse Dive's nursing test bank - Ati pathophisiology proctored exam. Take the full exam now
Full Explanation
Choice A reason: Alpha cells of the pancreas do not produce insulin. Insulin is produced by the beta cells of the pancreas. Therefore, the absence of alpha cells would not affect insulin secretion.
Choice B reason: The primary function of alpha cells in the pancreas is to produce and secrete glucagon. Glucagon is a hormone that raises blood glucose levels by promoting the conversion of glycogen to glucose in the liver. Without alpha cells, the body would not be able to secrete glucagon, leading to issues with glucose regulation.
Choice C reason: Somatostatin and gastrin are not secreted by alpha cells. Somatostatin is produced by delta cells of the pancreas and other parts of the digestive system, while gastrin is primarily produced by G cells in the stomach lining. Therefore, the absence of alpha cells would not affect the secretion of somatostatin and gastrin.
Choice D reason: Pancreatic polypeptides are produced by PP cells (pancreatic polypeptide cells) in the pancreas. The absence of alpha cells would not impact the secretion of pancreatic polypeptides.
Similar Questions
The TNM (Tumor size, Node (lymph) & Metastases) classification is not used for brain tumors for:
A. Most patients with CNS tumors develop metastatic disease
Most patients with CNS tumors do not develop metastatic disease. Central nervous system (CNS) tumors, including brain tumors, typically do not metastasize outside the CNS. Instead, they grow and exert pressure on adjacent brain structures, leading to neurological symptoms.
B. Brain tumors are more deadly
While brain tumors can be very deadly, the TNM classification system is not avoided due to the lethality of the tumors. The main reason for not using the TNM system is because the classification criteria do not align well with the unique aspects of brain tumors.
C. Tumor size is less relevant than the location and histology
Tumor size is less relevant than the location and histology for brain tumors. The location of the tumor within the brain and its histological characteristics (e.g., type, grade, and molecular features) are more critical for prognosis and treatment planning. Brain tumors can cause significant clinical issues even when small, depending on their location.
D. Brain tumors have poor prognosis
Brain tumors can have a poor prognosis, but this is not the reason the TNM classification is not used. The classification system's limitation is primarily due to the fact that brain tumors' behavior and treatment considerations depend more on their location and histological features than on tumor size, nodal involvement, and metastasis, which are the focus of the TNM system.
Full Explanation
Choice A reason: Most patients with CNS tumors do not develop metastatic disease. Central nervous system (CNS) tumors, including brain tumors, typically do not metastasize outside the CNS. Instead, they grow and exert pressure on adjacent brain structures, leading to neurological symptoms.
Choice B reason: While brain tumors can be very deadly, the TNM classification system is not avoided due to the lethality of the tumors. The main reason for not using the TNM system is because the classification criteria do not align well with the unique aspects of brain tumors.
Choice C reason: Tumor size is less relevant than the location and histology for brain tumors. The location of the tumor within the brain and its histological characteristics (e.g., type, grade, and molecular features) are more critical for prognosis and treatment planning. Brain tumors can cause significant clinical issues even when small, depending on their location.
Choice D reason: Brain tumors can have a poor prognosis, but this is not the reason the TNM classification is not used. The classification system's limitation is primarily due to the fact that brain tumors' behavior and treatment considerations depend more on their location and histological features than on tumor size, nodal involvement, and metastasis, which are the focus of the TNM system.
The release of insulin is caused by:
A. Increased lipid breakdown
Increased lipid breakdown does not directly cause the release of insulin. Insulin is a hormone that facilitates glucose uptake by cells and helps regulate blood sugar levels. Lipid metabolism is primarily regulated by other mechanisms and hormones, such as glucagon and epinephrine.
B. Decreased blood glucose level
Decreased blood glucose level would not stimulate insulin release. In fact, low blood glucose levels would signal the pancreas to reduce insulin secretion. Instead, glucagon would be released to increase blood glucose levels by stimulating the conversion of glycogen to glucose in the liver.
C. Increased protein breakdown
Increased protein breakdown does not directly trigger the release of insulin. Protein metabolism involves amino acids and other metabolic pathways, but insulin release is primarily regulated by blood glucose levels.
D. Increased blood glucose level
The release of insulin is caused by increased blood glucose levels. When blood glucose levels rise, such as after eating a meal, the beta cells in the pancreas secrete insulin to help cells absorb glucose from the bloodstream, thereby lowering blood glucose levels and maintaining homeostasis.
Full Explanation
Choice A reason: Increased lipid breakdown does not directly cause the release of insulin. Insulin is a hormone that facilitates glucose uptake by cells and helps regulate blood sugar levels. Lipid metabolism is primarily regulated by other mechanisms and hormones, such as glucagon and epinephrine.
Choice B reason: Decreased blood glucose level would not stimulate insulin release. In fact, low blood glucose levels would signal the pancreas to reduce insulin secretion. Instead, glucagon would be released to increase blood glucose levels by stimulating the conversion of glycogen to glucose in the liver.
Choice C reason: Increased protein breakdown does not directly trigger the release of insulin. Protein metabolism involves amino acids and other metabolic pathways, but insulin release is primarily regulated by blood glucose levels.
Choice D reason: The release of insulin is caused by increased blood glucose levels. When blood glucose levels rise, such as after eating a meal, the beta cells in the pancreas secrete insulin to help cells absorb glucose from the bloodstream, thereby lowering blood glucose levels and maintaining homeostasis.
Hyperglycemic Hyperosmolar Nonketoic (HHNK) is an acute complication of:
A. Gestation Diabetes
Gestational diabetes is a form of diabetes that occurs during pregnancy and typically resolves after childbirth. It is not typically associated with Hyperglycemic Hyperosmolar Nonketoic (HHNK) Syndrome, which is a specific complication of type 2 diabetes.
B. Type 2 Diabetes
Type 2 diabetes is characterized by insulin resistance and high blood glucose levels. HHNK is a serious acute complication of type 2 diabetes, occurring when blood glucose levels become extremely high, leading to severe dehydration and hyperosmolarity without significant ketoacidosis. This condition requires immediate medical attention.
C. Type 1 & Type 2 Diabetes
While both type 1 and type 2 diabetes involve issues with blood glucose regulation, HHNK is specifically associated with type 2 diabetes. Type 1 diabetes complications more commonly include Diabetic Ketoacidosis (DKA), rather than HHNK.
D. Type 1 Diabetes
Type 1 diabetes is characterized by the body's inability to produce insulin, leading to high blood glucose levels. However, the primary acute complication of type 1 diabetes is Diabetic Ketoacidosis (DKA), not HHNK. HHNK is distinct to type 2 diabetes, where insulin resistance leads to extremely high blood glucose levels and severe dehydration.
Full Explanation
Choice A reason: Gestational diabetes is a form of diabetes that occurs during pregnancy and typically resolves after childbirth. It is not typically associated with Hyperglycemic Hyperosmolar Nonketoic (HHNK) Syndrome, which is a specific complication of type 2 diabetes.
Choice B reason: Type 2 diabetes is characterized by insulin resistance and high blood glucose levels. HHNK is a serious acute complication of type 2 diabetes, occurring when blood glucose levels become extremely high, leading to severe dehydration and hyperosmolarity without significant ketoacidosis. This condition requires immediate medical attention.
Choice C reason: While both type 1 and type 2 diabetes involve issues with blood glucose regulation, HHNK is specifically associated with type 2 diabetes. Type 1 diabetes complications more commonly include Diabetic Ketoacidosis (DKA), rather than HHNK.
Choice D reason: Type 1 diabetes is characterized by the body's inability to produce insulin, leading to high blood glucose levels. However, the primary acute complication of type 1 diabetes is Diabetic Ketoacidosis (DKA), not HHNK. HHNK is distinct to type 2 diabetes, where insulin resistance leads to extremely high blood glucose levels and severe dehydration.